先天性A型血友病患者死亡率的系统文献综述
该系统综述检索2010年1月至2020年3月Medline、Embase及临床试验注册库,纳入17项观察性研究,评估先天性A型血友病人群死亡率与死因。结果显示死亡率随时间总体下降,与年龄及血友病严重程度强相关,合并HIV或HCV感染时死亡风险升高,出血、HIV、HCV及肝病为主要死因,但报告不完整且异质。
要点
- 先天性A型血友病患者死亡率高于一般人群,重型及合并HIV/HCV感染者尤为显著。
- 死亡率随时间总体下降,但1980至1990年代因HIV/HCV感染出现高峰。
- 出血、HIV、HCV及肝病为主要死因,各人群、国家及年代间存在差异。
核心结论
- 先天性A型血友病患者死亡率高于一般人群,重型及合并HIV或HCV感染者风险更高。
- 死亡率随时间总体下降,但1980至1990年代因HIV/HCV感染出现高峰。
- 出血、HIV、HCV及肝病为主要死因,但报告不完整且异质限制证据强度。
- 需要统一的死亡率与死因报告方法来评估新治疗模式的影响。
研究设计与样本
- 系统文献综述,检索Medline、Embase及临床试验注册库2010年1月至2020年3月发表文献。
- 检索词为血友病A、死亡率、死因,排除干预性研究、未报告死亡的研究及仅涉及血友病B、获得性血友病或混合其他凝血病的研究。
- 共识别7818条唯一记录,最终分析17项观察性研究。
主要发现
- 17项研究中6项报告死亡率,5项报告死亡比值。
- 死亡率随时间总体下降,但1980至1990年代因HIV/HCV感染出现高峰。
- 死亡率与年龄及血友病严重程度强相关。
- 与一般人群相比死亡风险升高,重型血友病及合并HIV或HCV感染者尤为明显。
- 15项研究报告死因,各人群、国家及年代间存在差异;出血、HIV、HCV及肝病为主要死因。
临床怎么用
- 临床应关注先天性A型血友病患者尤其是重型及合并HIV/HCV感染者的死亡风险。
- 出血、HIV、HCV及肝病为主要死因,提示综合管理需覆盖感染与肝病相关并发症。
局限性
- 死亡及死因报告不完整且异质,限制证据强度。
- 需要统一的死亡率与死因报告方法以更好理解死亡情况并评估新治疗模式的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Against a background of a rapidly evolving treatment landscape, a contemporary, evidence-based consolidated understanding of mortality in people with congenital hemophilia A (PwcHA) is lacking. This systematic literature review examines the available data on mortality and causes of death in PwcHA to enable a better understanding of fatalities in PwcHA and evaluate the impact of new treatment paradigms on mortality. A systematic literature review of observational studies was conducted by searching Medline, Embase, and clinical trials registries for articles published from January 2010 to March 2020, using the search terms: hemophilia A (HA), mortality, cause of death. Interventional studies, studies not reporting fatalities, and those reporting only on hemophilia B, acquired HA, or mixed other coagulopathies were excluded. Overall, 7818 unique records were identified and 17 were analyzed. Of these, six reported mortality rates and five reported mortality ratios. Mortality generally decreased over time, despite a spike associated with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) infection in the 1980s and 1990s. Mortality was strongly correlated with age and hemophilia severity. People with hemophilia had a raised mortality risk compared with the general population, particularly in severe hemophilia, and when infected with HIV or HCV. Causes of death varied across populations, countries, and time in 15 identified studies; however, incomplete and heterogeneous reporting limits evidence. Hemorrhage, HIV, HCV, and hepatic disease were the leading causes of death. A unified approach to reporting mortality and cause of death is needed to understand mortality in PwcHA as treatments continue to advance.
引用
- Hay CRM, Nissen F, Pipe SW, et al. Mortality in congenital hemophilia A - a systematic literature review. J Thromb Haemost. 2021. PMID: 33331043. doi:10.1111/jth.15189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。